BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34948346)

  • 21. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways.
    Liu J; Albrecht AM; Ni X; Yang J; Li M
    Curr Mol Med; 2013 Mar; 13(3):352-7. PubMed ID: 23331007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A.
    Shou T; Yang H; Lv J; Liu D; Sun X
    Mol Med Rep; 2019 Feb; 19(2):1049-1055. PubMed ID: 30483744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme.
    González-Gómez P; Sánchez P; Mira H
    Mol Neurobiol; 2011 Dec; 44(3):235-49. PubMed ID: 21728042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCMV-encoded miR-UL112-3p promotes glioblastoma progression via tumour suppressor candidate 3.
    Liang Q; Wang K; Wang B; Cai Q
    Sci Rep; 2017 Mar; 7():44705. PubMed ID: 28303930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy.
    Xu JX; Yang Y; Zhang X; Luan XP
    Anat Rec (Hoboken); 2021 Feb; 304(2):342-352. PubMed ID: 32275350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-21: A key player in glioblastoma pathogenesis.
    Masoudi MS; Mehrabian E; Mirzaei H
    J Cell Biochem; 2018 Feb; 119(2):1285-1290. PubMed ID: 28727188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.
    Yu W; Liang S; Zhang C
    Neuromolecular Med; 2018 Dec; 20(4):452-474. PubMed ID: 30182330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR‑296‑3p promotes the proliferation of glioblastoma cells by targeting ICAT.
    Zhou J; Du G; Fu H
    Mol Med Rep; 2020 May; 21(5):2151-2161. PubMed ID: 32323769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
    Wang H; Liu D; Yang J
    Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
    Kouri FM; Ritner C; Stegh AH
    Cell Cycle; 2015; 14(24):3794-800. PubMed ID: 26506113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth of glioblastoma is inhibited by miR-133-mediated EGFR suppression.
    Xu F; Li F; Zhang W; Jia P
    Tumour Biol; 2015 Dec; 36(12):9553-8. PubMed ID: 26138587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
    Jana A; Narula P; Chugh A; Kulshreshtha R
    Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA Multiplayers in glioma. From bench to bedside.
    Rolle K
    Acta Biochim Pol; 2015; 62(3):353-65. PubMed ID: 26307768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
    Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
    Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
    BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development.
    Isachesku E; Braicu C; Pirlog R; Kocijancic A; Busuioc C; Pruteanu LL; Pandey DP; Berindan-Neagoe I
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
    Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
    Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells.
    Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O
    Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.